PharmExec Blog
Follow Us
RSS
Bookstore
Tag Archives: Big Pharma
The Seven-Billion Society: What's In It For Pharma?
On Monday, the world’s population hit the 7 billion mark, repeating a pattern of largely unrestrained growth that has endured for the last century: the world is now adding roughly one billion people every 12 years. The UN Population Fund (UNPF) estimates that, barring some unforeseen demographic or environmental/development shifts, the figure will reach just [...]
Tufts R&D Outlook for 2011: Pain Mixed with Promise
The Tufts Center for Drug Development issues its annual assessment of the state of R&D in Big Pharma, noting that industry faces a cumulative tide of challenges marked by a dramatic reversal in societal attitudes toward risk. Productivity gaps in the pipeline aside, perhaps the biggest problem is political — convincing stakeholders to strive for [...]
Posted in FDA, Gene therapy, R&D, Regulatory Also tagged FDA, forecast, monoclonal antibodies, R&D, risk sharing, Tufts Center for Drug Development 1 Comment
New Year Night Stalkers: What Will Keep the C-Suiters Awake in 2011
New Year Night Stalkers
Eight Strategic Issues that Should Keep “C Suiters” Reaching for the NoDoz in 2011
The consensus is that 2011 will be a bad year for big pharma. It must confront a breaking wave of patent expirations, while fiscal retrenchment has created an innovation cycle in reverse as payers find new ways to curb [...]
Posted in Manufacturing, Marketing, R&D, Regulatory, Strategy, Technology, compliance Also tagged 2011, C-Suite 5 Comments
2010: A Year of Big Layoffs for Big Pharma
What are the factors that are contributing to the layoffs that have taken place at virtually all the Big Pharma companies this year?
According to the newly released Job-Cut Announcement Report from outplacement consultancy firm Challenger, Gray & Christmas, pharma has cut more than 6,000 jobs in September alone, and more than 43,000 so far this [...]
Pharma Surges Ahead in Online Communications